The abstract is read at the publisher; the summary is JClub's.
Among screening-eligible current smokers in the NLST, low-dose CT screening is linked to 12% lower lung cancer mortality versus chest radiography (HR 0.88, 95% CI 0.79–0.97).
- Why it matters: Real-world comparisons of LDCT screening, smoking cessation, and their combination for mortality in current smokers eligible for lung cancer screening are limited.
- What they did: In a post-hoc NLST analysis of 31,560 continuous smokers and recent quitters, Cox models estimated associations of screening assignment and cessation within 2 years of enrollment with lung cancer–specific and all-cause mortality.
- The result: Recent quitting within 2 years is associated with substantially lower lung cancer and all-cause mortality than continued smoking in the CXR arm (HR 0.62 and 0.68), with similar reductions among recent quitters in the LDCT arm.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.